Delhi High Court
1664 cases · page 24 of 56
Showing 691–719The European Union Represented By The European Commission v.Union Of India & Ors.
The European Union challenged the deemed abandonment of two patent applications (11123/DELNP/2012 and 3466/DELNP/2013) filed under Indian law. The Petitioner argued that despite procedural delays involving multiple patent agents, they had taken steps to respond to the First Examination Reports (FERs). Citing exceptional circumstances and observations from a Parliamentary Standing Committee regarding the inflexibility of abandonment rules, the Delhi High Court set aside the abandonment orders.
The European Union Represented By The European Commission v.Union Of India & Ors.
The European Union challenged the deeming abandonment of two patent applications (11123/DELNP/2012 and 3466/DELNP/2013) filed under the Indian Patents Act. The Petitioner argued that delays, stemming from changes in legal counsel and communication issues with the initial patent agent, led to the abandonment orders. Citing exceptional circumstances and observations from a Parliamentary Standing Committee regarding the inflexibility of the Patent Act, the Delhi High Court set aside the abandonment orders.
Indiabulls Housing Finance Ltd. v.Www.Indiabullsdhanifinance.Co & Anr.
The Delhi High Court ruled in favor of Indiabulls Housing Finance Ltd., finding that the defendant's website and domain name were engaged in trademark infringement, passing off, and unfair competition. The court found that the use of deceptively similar marks ('Indiabulls', 'Dhani') and identical get-up was designed to mislead customers into believing the fraudulent site was affiliated with the Plaintiffs. Consequently, the defendant was permanently restrained from using the infringing marks and their website operation was suspended.
Novartis Ag v.Msn Laboratories Private Limited
Novartis filed a suit seeking permanent injunction against Msn Laboratories Private Limited for alleged infringement of Patent No. 237430 (Inhibitors of Tyrosine Kinases). The dispute centered on whether the Department of Pharmaceuticals' public notice constituted government authorization to manufacture the drug Nilotinib. The court, without considering the merits of infringement or validity, directed that Msn Laboratories must provide four weeks' advance notice before commencing commercial production.
Novartis Ag v.Centurion Remedies Private Limited
Novartis filed a suit seeking permanent injunction and damages against Centurion Remedies Private Limited for infringing Indian Patent No. 229051 concerning pharmaceutical compositions comprising Valsartan and NEP Inhibitors. The court clarified that the Department's Public Notice was merely to collate local manufacturers and did not constitute Government Authorization under Section 100 of the Patents Act, 1970. Consequently, the suit was decreed granting a permanent injunction against Centurion Remedies.
Novartis Ag v.Centurion Remedies Private Limited
Novartis filed a suit seeking permanent injunction and damages against Centurion Remedies Private Limited for alleged infringement of Indian Patent No. 233161. The court examined the defendant's affidavit, which claimed no commercial activity related to the patented drug ELTROMBOPAG OLAMINE/ REVOLADE. Furthermore, the Department of Pharmaceuticals clarified that its public notice was merely for collating local manufacturers and did not constitute government authorization under Section 100 of the Patents Act, 1970.
Novartis Ag v.Msn Laboratories Private Limited
Novartis filed a suit seeking permanent injunction and damages against MSN Laboratories for alleged infringement of Patent No. 283133 concerning Pyrrolopyrimidine compounds. The dispute also involved whether a public notice issued by the Department of Pharmaceuticals constituted government authorization to manufacture the patented drug, Ribociclib.
Shakthi Fashion & Anr. v.Burberry Limited
The Delhi High Court addressed a revision petition challenging the dismissal of an application to reject a plaint based on territorial jurisdiction in a trademark infringement suit. The court examined whether the cause of action had arisen within its jurisdiction, considering both past incidents in Bangalore and ongoing activities in New Delhi. While acknowledging the plaintiff's claims regarding online sales (IndiaMart) and local solicitation in Delhi, the High Court ultimately dismissed the revision petition, stating that the question of territorial jurisdiction is a mixed question of fact and law requiring evidence at trial.
Semco Infratech Pvt Ltd v.Simla Chemicals Pvt Ltd
This Delhi High Court judgment resolves a trademark dispute between Simla Chemicals (owner of SIMCO) and Semco Infratech (using SEMCO). The parties reached an amicable settlement, leading the court to decree the original suit in terms of this agreement. Under the settlement, Simla retains ownership of 'SIMCO' but is permitted to expand its product range, while Semco can continue using 'SEMCO' for specific goods and services, provided they pursue necessary registrations. The ruling provides a clear path forward for both parties to operate without ongoing litigation.
Sudhir Bhatia Trading As V.Bhatia International v.Central Government Of India & Ors
This Delhi High Court judgment addressed a challenge to the registration of the trademark 'LAXMAN REKHA' by arguing that the initial advertisement in the Trade Marks Journal was illegible. The petitioner sought to quash the advertisement and compel re-advertisement, claiming this error prejudiced their ability to file an opposition. However, the court ultimately dismissed the petition, emphasizing that while the Registrar has a duty to ensure proper advertising, the petitioner's significant delay in challenging the registration—despite learning of the issue years earlier—precluded the High Court from exercising its extraordinary writ jurisdiction.
M/S Subros Educational Society v.Union Of India
The Delhi High Court allowed an appeal filed by M/S Subros Educational Society against the refusal of registration for its trademark 'SBS World School'. The court found that the Registrar failed to properly consider the Appellant's existing registrations for similar marks under 'SBS' in Class 41. Consequently, the refusal order was set aside, and the matter was remanded back to the Registrar of Trademarks for fresh consideration.
Radico Khaitan Ltd v.The Registrar Of Trade Marks
The Delhi High Court heard an appeal filed by Radico Khaitan Ltd challenging the rejection of its trademark application for "EFKAY'S FIVE STAR MYSORE BRANDY." The court found that the Senior Examiner failed to properly consider the Appellant's existing assigned rights in 'EFKAY'S.' While this addressed the Section 11 objection, the court remanded the matter back to the Registrar. The examiner must now reconsider the application based on the remaining descriptive elements of the mark, ensuring a fair hearing for the appellant.
Radico Khaitan Ltd. v.Registrar Trade Marks
Radico Khaitan Ltd. appealed the rejection of its trademark application 'EFKAY'S XXX RUM (DEVICE)' by the Registrar of Trademarks, citing conflicts with existing marks. The appellant argued that several related 'EFKAYS' series marks had been legally assigned to them. The Delhi High Court acknowledged the arguments and directed all related appeals concerning similar mark rejections to be listed together for a comprehensive hearing.
Makind Pharma Limited v.The Registrar Of Trade Marks
The Delhi High Court allowed Makind Pharma Limited's appeal against the rejection of its trade mark application for "DON'T WORRY" in Class 3. The court held that, given the Appellant's existing registrations of the mark across various classes, the refusal based solely on lack of distinctiveness was unwarranted. The application was permitted to proceed for advertisement before acceptance, provided it is associated with the registered trademark 'MANKIND'S DON'T WORRY', and no exclusive rights are granted in the words 'DON'T' or 'WORRY' alone.
Jitendra Kohli v.The Controller Of Patents
Jitendra Kohli appealed the rejection of his patent application concerning an electronic tendering system. The Assistant Controller rejected the application under Section 3(k) for being a business method, based on the original process claims. The High Court found that the Assistant Controller erred by not considering the later-filed amended 'system and process claims', leading to the setting aside of the impugned order.
Jagran Prakashan Limited v.The Registrar Of Trade Marks, Delhi
Jagran Prakashan Limited appealed the abandonment of its trademark application for 'JAGRAN' in Class 12, which was initiated due to non-filing of a reply to the Examination Report (FER). The Delhi High Court ultimately dismissed the appeal, finding that the appellant had approached the court too belatedly. Despite acknowledging the appellant's existing rights in related marks, the court held that the delay in responding to the FER and filing the present appeal was too long to be condoned.
Starbucks Corporation v.Teaquila A Fashion Cafe & Anr.
The Delhi High Court ruled in favor of Starbucks Corporation, granting a permanent injunction against Teaquila A Fashion Cafe & Anr. for infringing the registered trademark 'FRAPPUCCINO' and engaging in passing off. Despite the defendants being proceeded ex parte, the court found them guilty of infringement based on the evidence presented by Starbucks. Furthermore, the court awarded damages to Starbucks, noting that while specific sales figures were lacking, notional damages could be granted given the established infringement.
The British School Society v.Sanjay Gandhi Educational Society & Anr.
The Delhi High Court ruled in favor of The British School Society, confirming an existing interim injunction against the Sanjay Gandhi Educational Society. The court found that the unauthorized and continuous use of the identical mark 'The British School' by the Defendants constituted misrepresentation and caused irreparable prejudice to the Plaintiff's goodwill. Consequently, the Defendants were mandated to change their school names effective May 1, 2022, ensuring a smooth transition for enrolled students.
Saga Lifesciences Limited v.Aristo Pharmaceuticals Pvt. Ltd.
In a trademark infringement suit concerning the brand 'ULTRAMOL', the Delhi High Court recognized Saga Lifesciences Limited as the prior adopter and user of the mark for pharmaceutical preparations. Despite initial procedural applications being disposed of, the court appointed a Local Commissioner to inspect the premises of Aristo Pharmaceuticals Pvt. Ltd. The commissioner is tasked with inventorying products bearing both 'ULTRAMOL' and 'ARISTO ULTRAMOL', and critically, examining the sales accounts of the defendant to assess the scope of alleged infringement.
Elcom Innovation Pvt Ltd v.Harish Sharma & Ors.
Elcom Innovation Pvt. Ltd. filed suit seeking permanent injunction against its erstwhile employee and shareholder, Harish Sharma, alleging misuse and disclosure of proprietary sensitive and highly confidential information/data. The plaintiff sought an interim injunction to prevent further leakage of this IP. However, the court dismissed both applications, finding that the plaintiff failed to make out a prima facie case for the grant of an interim injunction due to the vagueness of the claimed confidential information.
M/S Drs Logistics (P) Ltd & Another v.Google India Pvt Ltd & Anr
The Delhi High Court addressed applications filed by Drs Logistics against Google regarding trademark infringement via search engine advertising. The court recognized that using a registered trademark as a keyword could lead to consumer confusion, diverting traffic from the plaintiff's site to competitors. Consequently, the court granted interim injunctions requiring Google and other defendants to investigate any complaints of misuse and remove or block advertisements found to be infringing or causing passing off.
Sanofi India Limited v.Ridley Life Science Private Limited
Sanofi India Limited filed a suit against Ridley Life Science Private Limited alleging continuous violation of an earlier injunction order, specifically regarding the sale of products under the marks 'CONCIFLAM' and 'CORIFLAM'. The Plaintiff claimed that these infringing products were being sold despite the May 2021 restraint on using marks similar to its registered trademark 'COMBIFLAM'. The court noted the defendant's history of alleged habitual infringement in pharmaceutical preparations. Consequently, the court directed the defendant to submit detailed sales figures and imposed a significant deposit amount due to the persistent violations.
Government E Marketplace v.Unilex Consultants & Ors.
The Delhi High Court ruled in favor of the Government E Marketplace (GeM) against various parties for misusing its brand name. The plaintiff alleged that several defendants were registering or using 'GeM' as a domain name or URL extension, misleading the public into believing they were associated with the official portal. The court granted permanent injunctions and ordered the suspension of multiple infringing domains, reinforcing the protection of government digital brands against unauthorized commercial exploitation.
Dr. Reddy's Laboratories Limited & Anr. v.The Controller Of Patents & Ors.
This judgment addressed an application seeking dismissal of a patent revocation petition on the ground that it was barred by limitation. The court examined Section 64 of the Patents Act and the concept of a 'person interested'.
Novartis AG v.Medipol Pharmaceuticals India Pvt Ltd
Novartis AG filed a suit seeking permanent injunction against Medipol Pharmaceuticals India Pvt Ltd and Metrochem Api Private Limited for infringing its patent (No. 233161) covering 'Eltrombopag Olamine', the API in Revolade. The court found that both defendants acknowledged the validity of the patent and admitted they had not manufactured or commercially sold the patented product, leading to a decree granting permanent injunction during the patent's term.
Chugai Seiyaku Kabushiki Kaisha v.Controller Of Patents And Design
Chugai Seiyaku Kabushiki Kaisha appealed the rejection of its patent application (No. 201617023236) for a solid preparation containing Tofogliflozin in monohydrate crystal form. The Controller rejected the application, citing lack of inventive step and falling under Section 3(d) because it was merely a new use/form of a known drug without enhanced efficacy.
M/S Blue Heaven Cosmetics Private Limited. v.Deepak Arora & Anr.
The Delhi High Court ruled in favor of M/S Blue Heaven Cosmetics, ordering the cancellation and rectification of a conflicting trademark registered by Deepak Arora ('MARC HEAVEN'). The court found that 'MARC HEAVEN' was deceptively similar to the Petitioner's established mark 'BLUE HEAVEN,' particularly due to the appropriation of the dominant feature 'Heaven.' Citing Sections 9 and 11 of the Trade Marks Act, the judgment held that the Respondent's registration lacked distinctive character and caused public confusion.
Red Bull Ag v.Pepsico India Holdings Pvt Ltd & Anr
The Delhi High Court dismissed Red Bull's application for an interim injunction against Pepsico India Holdings regarding the use of the tagline 'STIMULATES MIND. ENERGIZES BODY.' by their product STING. The court found that both taglines are descriptive and laudatory in nature, meaning the plaintiff failed to establish a prima facie case at this stage. Furthermore, the balance of convenience favored the defendants given their long-standing market presence with the tagline.
Agriboard International Llc v.Deputy Controller Of Patents And Designs
Agriboard International LLC appealed the Deputy Controller's order refusing its patent application for 'Efficient Method and Apparatus for Producing Compressed Structural Fiberboard' on grounds of lack of inventive step. The petitioner argued that the refusal was cryptic and lacked proper reasoning regarding the differences between the subject invention and the cited prior art (D1).
Novartis Ag v.Windlas Biotech Pvt Ltd
Novartis initiated multiple suits against various defendants, including Windlas Biotech and Eris Lifesciences, alleging infringement of Indian Patent No. IN229051, which covers a combination drug (Valsartan + Sacubitril) used to treat cardiovascular disease. The Delhi High Court addressed applications seeking interim injunctions and access to distribution details. While the court maintained an interim injunction against manufacturing and selling the patented composition, it also directed Eris Lifesciences Limited to deposit Rs. 5 crores due to the marketing of stock post-infringement.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.